Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVCR | EYPT | NRIX | ||
| Company | Novocure Ltd Ord Sh | Eyepoint Inc | Nurix Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.43 | 18.16 | 19.03 | ||
| High | 13.64 | 18.43 | 19.54 | ||
| Low | 13.28 | 17.79 | 18.81 | ||
| Latest | 13.35 | 18.25 | 19.33 | ||
| Change | -0.13 | -0.04 | +0.03 | ||
| % Change | -0.96% | -0.22% | +0.16% | ||
| Volume | 255,099 | 347,270 | 360,093 | ||
| 20-Day Average Volume | 1,738,025 | 1,270,338 | 1,975,024 | ||
| Previous Close | 13.48 | 18.29 | 19.30 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 12.69 | 16.86 | 18.72 | ||
| 20-Day Raw Stochastic | 81.76% | 86.82% | 53.09% | ||
| 20-Day Relative Strength | 55.73 | 65.54 | 64.92 | ||
| Weighted Alpha | -44.64 | +145.53 | +20.75 | ||
| Today's Opinion | 8% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | 8% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 88% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.28% since 12/19/25 | +5.48% since 12/19/25 | +5.08% since 12/19/25 | ||
| Low | 12.80 on 12/22/25 | 17.34 on 12/22/25 | 18.61 on 12/22/25 | ||
| High | 13.97 on 12/22/25 | 19.00 on 12/22/25 | 19.84 on 12/24/25 | ||
| 1-Month | |||||
| %Chg | +4.53% since 11/28/25 | +23.97% since 11/28/25 | +10.07% since 11/28/25 | ||
| Low | 10.79 on 12/02/25 | 13.61 on 12/02/25 | 16.02 on 12/02/25 | ||
| High | 13.97 on 12/22/25 | 19.11 on 12/08/25 | 22.50 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +3.64% since 09/29/25 | +30.85% since 09/29/25 | +109.70% since 09/29/25 | ||
| Low | 10.70 on 11/07/25 | 9.65 on 11/05/25 | 8.85 on 10/02/25 | ||
| High | 14.77 on 10/06/25 | 19.11 on 12/08/25 | 22.50 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | -25.61% since 06/27/25 | +90.72% since 06/27/25 | +67.18% since 06/27/25 | ||
| Low | 10.70 on 11/07/25 | 8.95 on 07/01/25 | 8.19 on 09/23/25 | ||
| High | 18.70 on 06/30/25 | 19.11 on 12/08/25 | 22.50 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,509,517 | 1,514,174 | 1,483,842 | ||
| Shares Outstanding, K | 111,982 | 82,787 | 76,883 | ||
| Annual Sales | 605,220,000 | 43,270,000 | 54,550,000 | ||
| Annual Net Income | -168,630,000 | -130,870,000 | -193,570,000 | ||
| Last Quarter Sales | 167,200,000 | 970,000 | 7,890,000 | ||
| Last Quarter Net Income | -37,270,000 | -59,730,000 | -86,420,000 | ||
| 60-Month Beta | 0.83 | 1.67 | 1.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 10/30/25 | -0.85 on 11/05/25 | -1.03 on 10/09/25 | ||
| Latest Earnings Date | 02/26/26 | 03/04/26 | 01/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||